Product
Supplier
Encyclopedia
Inquiry
Paclitaxel 99% white powder buy - large image1
Paclitaxel 99% white powder buy - image1

Paclitaxel 99% white powder

GMP 5 Inquiries

Unit Price: Get Latest Price
CAS No.:

33069-62-4

Content:

99%

Port:

shanghai

Packaging:

1kg/bag

Price valid (until):

2021-05-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

calcium L-5-methyltetrahydrofolate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Please enter the product introduction information...

    ItemsSpecifications
    AppearanceWhite or of- white powder or crystlline power,odorless
    SolubilityVery soluble in N,N-Dimethylformamide,Soluble in methanol,Sparingly soluble inglacial acetic acid, Very slightly soluble inchloroform, Practically insoluble in water.
    Melting Point152°C~156°C

    Certificates

    Basic Info
    Product Name:

    Paclitaxel

    Other Name:

    Benzenepropanoic acid,β-(benzoylamino)-α-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,(αR,βS)-;Tax-11-en-9-one,5β,20-epoxy-1,2α,4,7β,10β,13α-hexahydroxy-,4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine;Benzenepropanoic acid,β-(benzoylamino)-α-hydroxy-,6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,[2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-;7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.;Taxol;NSC 125973;Taxol A;Paclitaxel;BMS 181339-01;Yewtaxan;Plaxicel;ABI 007;TaxAlbin;QW 8184;Ebetaxel;Capxol;MBT 0206;Abraxane;Genexol-PM;Pacliex;Genexol;Genetaxyl;NK 105;Mitotax;OncoGel;Onxal;DHP 107;EndoTAG 1;Genaxol;Intaxel;Taxus;TAXUS stent;(-)-Paclitaxel;Taxus Liberte;EmPAC;Tocosol Paclitaxel;Cyclopax;Zisu;LEP-ETU;Liposome-entrapped paclitaxel easy-to-use;Paxene;Infinnium;Padexol;Sindaxel;Nanoxel;5β,20-Epoxy-1,2a,4,7β,10β,13α-hexahydroxy-tax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine;PTX;Cypher select;Coroflex Please;Nab-paclitaxel;TAXUS Express;IG 001;Cynviloq;IG 002;157069-30-2;1203669-79-7;2376186-34-2

    CAS No.:

    33069-62-4

    Molecular Formula:

    C47H51NO14

    InChIKeys:

    InChIKey=RCINICONZNJXQF-MZXODVADSA-N

    Molecular Weight:

    853.90600

    Exact Mass:

    853.91

    EC Number:

    608-826-9

    NSC Number:

    358882

    UN Number:

    2811

    DSSTox ID:

    DTXSID9023413

    Color/Form:

    White to off-white crystalline powder|Needles from aqueous methanol

    HScode:

    2932999021

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    221.29000

    XLogP3:

    4.12660

    Appearance:

    Taxol appears as needles (from aqueous methanol) or fine white powder. An anti-cancer drug.

    Density:

    1.39g/cm3

    Melting Point:

    213-216 °C (decomp)

    Boiling Point:

    957.115ºC at 760 mmHg

    Flash Point:

    532.644ºC

    Refractive Index:

    -49 ° (C=1, MeOH)

    Water Solubility:

    methanol: 50 mg/mL, clear, colorless

    Storage Conditions:

    2-8ºC

    Toxicity:

    LD50 intraperitoneal in mouse: 128mg/kg

    Specific rotation:

    Specific optical rotation: -49 deg at 20 °C/D (methanol); UV max absorption 2 (methanol): 227, 273, nm (E= 29,800,1700)

    Collision Cross Section:

    278.9 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Experimental Properties:

    Clear colorless to slightly yellow viscous solution /Paclitxel Injection USP/

    Air and Water Reactions:

    May be sensitive to prolonged exposure to moisture. (NTP, 1992).

    Reactive Group:

    Alcohols and Polyols

    Hazard Identification

    Classification of the substance or mixture

    Skin irritation, Category 2

    Skin sensitization, Category 1

    Serious eye damage, Category 1

    Specific target organ toxicity – single exposure, Category 3

    Reproductive toxicity, Category 2

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 4

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H315 Causes skin irritation

    H317 May cause an allergic skin reaction

    H318 Causes serious eye damage

    H335 May cause respiratory irritation

    H361 Suspected of damaging fertility or the unborn child

    H413 May cause long lasting harmful effects to aquatic life

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P272 Contaminated work clothing should not be allowed out of the workplace.

    P271 Use only outdoors or in a well-ventilated area.

    P203 Obtain, read and follow all safety instructions before use.

    P273 Avoid release to the environment.

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P321 Specific treatment (see ... on this label).

    P332+P317 If skin irritation occurs: Get medical help.

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P333+P317 If skin irritation or rash occurs: Get medical help.

    P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    P317 Get medical help.

    P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    P319 Get medical help if you feel unwell.

    P318 IF exposed or concerned, get medical advice.

    Storage

    P403+P233 Store in a well-ventilated place. Keep container tightly closed.

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    calcium L-5-methyltetrahydrofolate

    Location:

    No.111,Qinxin Rd,Donggang Town,Xishan Dist,Wuxi,China.

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A

    Average lead Time:

    300

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    101-200

    Year of Establishment:

    2004

    Certifications:

    KOSEHR

    Wuxi Taxus Pharmaceutical Co.,Ltd was established in 2004,and a bio-pharmaceutical company under the HODO Group which is the top 500 private  enterprises  . It is mainly engaged in the research, development, production and sales of paclitaxel-based anti-tumor drugs. The complete industrial chain was established,from the cultivation of yew resources to the processing of yew branches and leaves, paclitaxel primary products, paclitaxel series of raw materials and intermediates to preparations . Products include paclitaxel, docetaxel, cabazitaxel, 10-DAB, oxaliplatin, dresian hydrochloride, allopurinol, L-5-methylfolate, L-5-methylfolate, etc. API, and paclitaxel injection.

    The company has strong technical strength. In 2018, the company established the Hongdoushan International Pharmaceutical Research and Development Company in New York, focusing on the research and development and introduction of anticancer drugs. At present, the Hongdoushan research and development center hires the Doctor returned from abroad to lead the research and development of new products, and currently has more than 30 senior engineers. Whats more, the R&D Center has established close cooperative relations with Jiangsu Academy of Agricultural Sciences, Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Tsinghua University, and foreign research institutes.

    The company's paclitaxel API has obtained the US DMF registration number (25759), and is registered in Korea, India, Iran, Russia, Belarus and other countries. It is sold at home and abroad, mainly exported to India, South America, Russia, Egypt and other countries and regions,and praised

     


  • Inquiry History
    5 Inquiries
    Country Product Purchase Quantity Date Posted
    Algeria

    Paclitaxel

    5 G Apr 16, 2025
    United States

    paclitaxel

    25 G Oct 11, 2024
    India

    Paclitaxel

    1 KG Feb 16, 2026
    India

    Paclitaxel

    10 KG Jul 8, 2024
    India

    Paclitaxel

    5 G Feb 9, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.